Showing results (131-140 of 143) with videos related to
Sort By:
Pageof 15
The Journal of Chemical Physics|August 20, 2014
Spectroscopy and picosecond dynamics of aqueous NO₂Ane Riis Gadegaard, Jan Thøgersen, Svend Knak Jensen, et al.Scandinavian Journal of Gastroenterology|October 22, 2013
Underpinning the repurposing of anthracyclines towards colorectal cancer: assessment of topoisomerase II alpha gene copy number alterations in colorectal cancerSune Boris Nygård, Ib Jarle Christensen, David Hersi Smith, et al.BMC Cancer|May 19, 2015
The glutamate transport inhibitor DL-Threo-β-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cellsElena Pedraz-Cuesta, Sandra Christensen, Anders A Jensen, et al.Physical Review Letters|August 18, 2023
Nonadiabatic Laser-Induced Alignment Dynamics of Molecules on a SurfaceLorenz Kranabetter, Henrik H Kristensen, Areg Ghazaryan, et al.Journal of Medicinal Chemistry|July 18, 2014
A novel class of bis- and tris-chelate diam(m)inebis(dicarboxylato)platinum(IV) complexes as potential anticancer prodrugsHristo P Varbanov, Simone Göschl, Petra Heffeter, et al.Journal of Chemical Theory and Computation|March 31, 2025
Calculating the Energy Profile of an Enzymatic Reaction on a Quantum ComputerPatrick Ettenhuber, Mads Bøttger Hansen, Pier Paolo Poier, et al.BMC Cancer|February 13, 2016
A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplificationLine S Tarpgaard, Camilla Qvortrup, Sune B Nygård, et al.Plos One|April 12, 2013
Mechanisms of topoisomerase I (TOP1) gene copy number increase in a stage III colorectal cancer patient cohortDavid Hersi Smith, Ib Jarle Christensen, Niels Frank Jensen, et al.Nature Chemistry|February 22, 2017
Synthesis of ent-BE-43547A1 reveals a potent hypoxia-selective anticancer agent and uncovers the biosynthetic origin of the APD-CLD natural productsNikolaj L Villadsen, Kristian M Jacobsen, Ulrik B Keiding, et al.BMC Genomics|May 23, 2015
The potential role of Alu Y in the development of resistance to SN38 (Irinotecan) or oxaliplatin in colorectal cancerXue Lin, Jan Stenvang, Mads Heilskov Rasmussen, et al.Pageof 15